TP53 and B-cell chronic lymphocytic leukemia: In summary, we demonstrate that MinION is a suitable tool for the detection of TP53 gene mutations in patients affected by CLL, and propose that its low costs and ease of use may potentially expand its field of applications to other cancer genes.